Furthermore, imaging technologies, including [99mTc]Tc-hynicy-ly SPECT and ultrasonic radiographic features (URFs), have demonstrated the ability to assess HER2 expression in breast cancer patients (47, 48). Here, ERBB2 is linked to breast carcinoma.